You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國電建(601669.SH):簽署70.76億元巴西菲奧克魯斯衞生生物技術產業綜合體項目施工合同
格隆匯 12-26 18:29

格隆匯12月26日丨中國電建(601669.SH)公佈,近日,中國電力建設股份有限公司下屬子公司中國電建集團國際工程有限公司所屬分公司中國電建巴西分公司與巴西AFFIT公司組成承包商聯營體,與巴西新疫苗終端加工中心項目公司簽署了巴西菲奧克魯斯衞生生物技術產業綜合體項目施工合同,合同金額約為70.76億元人民幣。該項目位於巴西東南部里約熱內盧州聖克魯斯市,距里約熱內盧市約73km。該項目主要工程範圍包括疫苗工廠的發貨倉庫、包裝車間填充車間、灌裝與包裝車間、收貨倉庫、行政辦公等建築物以及配套基礎設施的施工建設,業主已採購的生產設備安裝、調試以及空調等其他輔助設備的採購、安裝與調試等。合同工期約44個月。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account